Marker Therapeutics, Inc. (MRKR)
1.48
-0.10
(-6.33%)
USD |
NASDAQ |
Feb 27, 16:00
1.48
0.00 (0.00%)
After-Hours: 20:00
Marker Therapeutics EPS Diluted (Quarterly) : -0.1193 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 0.2025 |
| Viridian Therapeutics, Inc. | -0.423 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Kiniksa Pharmaceuticals International Plc | 0.1741 |
| Neurocrine Biosciences, Inc. | 1.482 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.999M |
| Revenue (Quarterly) | 1.233M |
| Total Expenses (Quarterly) | 3.232M |
| Enterprise Value | 5.733M |
| Profit Margin (Quarterly) | -162.1% |
| Earnings Yield | -83.04% |
| Normalized Earnings Yield | -83.04 |